loader

knight therapeutics inc.

LATEST ARTICLES

Knight Therapeutics Announces Launch of TAVALISSE® in Mexico

Knight to Present at the 2026 RBC Capital Markets Global Healthcare Conference in New York City

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil

Knight Therapeutics Reports First Quarter 2026 Results

Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call

Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. ranks on The Globe and Mail's second annual Canada's Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity

Knight Amends Normal Course Issuer Bid

Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results

Notice of Knight Therapeutics' Fourth Quarter and Year End 2025 Results Conference Call

Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® in Brazil

Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES